| scholarly article | Q13442814 |
| P50 | author | Margaret M Redfield | Q98243295 |
| Josef Kořínek | Q43485489 | ||
| Christopher G. Scott | Q47399721 | ||
| P2093 | author name string | Kent R Bailey | |
| Robert D Simari | |||
| John C Burnett | |||
| Horng H Chen | |||
| Guido Boerrigter | |||
| Adriana Harbuzariu | |||
| Harald Froehlich | |||
| Barry A Boilson | |||
| Brian P Shapiro | |||
| Sinny Delacroix | |||
| Katarina Larsen | |||
| P2860 | cites work | Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study | Q57073033 |
| CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure | Q61403155 | ||
| The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering | Q71558484 | ||
| Effects of glucocorticoids and mineralocorticoids on proliferation and maturation of human peripheral blood stem cells | Q73047622 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells | Q74033028 | ||
| Leukocyte telomere length and cardiovascular disease in the cardiovascular health study | Q79249738 | ||
| Telomere length of cord blood-derived CD34(+) progenitors predicts erythroid proliferative potential | Q79897780 | ||
| Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease | Q81432945 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Aldosterone in congestive heart failure | Q34472458 | ||
| Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets | Q35179253 | ||
| A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism | Q35613063 | ||
| Telomeres and cardiovascular disease: does size matter? | Q35697295 | ||
| The bone marrow--cardiac axis of myocardial regeneration | Q36174197 | ||
| Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects | Q36583152 | ||
| Mineralocorticoid receptor activation and cardiac fibrosis. | Q36772857 | ||
| Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? | Q36774947 | ||
| Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction | Q36841345 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study | Q40251749 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| ENDOTHELIUM GROWN FROM CIRCULATING BLOOD ON ISOLATED INTRAVASCULAR DACRON HUB | Q42414133 | ||
| Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface | Q42738909 | ||
| Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure | Q43576511 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype | Q44513066 | ||
| Mineralocorticoid hormones exert dramatic effects on pluripotent human stem cell progeny | Q44559032 | ||
| Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats | Q45146691 | ||
| Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability | Q46786249 | ||
| Mineralocorticoid signaling in transition to heart failure with normal ejection fraction | Q46845277 | ||
| Aldosterone and telomere length in white blood cells | Q46902298 | ||
| Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. | Q47398233 | ||
| Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure | Q48235146 | ||
| Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure | Q48260348 | ||
| Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors | Q49053811 | ||
| Aldosterone impairs bone marrow-derived progenitor cell formation. | Q53611018 | ||
| Telomerase activity in surgical specimens and fine-needle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues. | Q54765689 | ||
| P433 | issue | 5 | |
| P921 | main subject | ventricular dysfunction | Q54911334 |
| P304 | page(s) | 635-642 | |
| P577 | publication date | 2010-06-23 | |
| P1433 | published in | Circulation: Heart Failure | Q2865806 |
| P1476 | title | Regulation of circulating progenitor cells in left ventricular dysfunction | |
| P478 | volume | 3 |
Search more.